Piramal Pharma Limited schließt die Übernahme einer Mehrheitsbeteiligung an Yapan Bio Private Limited ab

Positive

AI Analysis

Summary

Piramal Pharma Limited has completed its acquisition of a majority stake in Yapan Bio Private Limited, a contract development and manufacturing organization specializing in Phase I and II clinical trial manufacturing for vaccines and biologics.

Outcome Details

Piramal Pharma completed acquisition of majority stake in Yapan Bio

Importance:6/10

Sentiment:

0.60

M&AAcquisitionCDMOVaccinesBiologicsGMP Manufacturing

Read the original article

Published by PR Newswire Pharma on August 19, 2026 10:00 PM

Read Original